Filing Details
- Accession Number:
- 0000899243-22-011321
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-03-16 20:52:26
- Reporting Period:
- 2022-03-12
- Accepted Time:
- 2022-03-16 20:52:26
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1501134 | Invitae Corp | NVTA | Services-Medical Laboratories (8071) | 271701898 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1640322 | L Robert Nussbaum | C/O Invitae Corporation 1400 16Th Street San Francisco CA 94103 | Chief Medical Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2022-03-12 | 14,705 | $0.00 | 260,755 | No | 4 | A | Direct | |
| Common Stock | Disposition | 2022-03-14 | 19,588 | $6.69 | 241,167 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | A | Direct | |
| No | 4 | S | Direct |
Footnotes
- Shares issued upon settlement of a restricted stock unit award that vests in two equal installments, with 1/2 of the remaining award vesting on March 12, 2023, subject to continued service with the issuer through such vesting date.
- Includes an aggregate of 91,486 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested.
- Represents the sale of shares to cover tax withholding obligations associated with the vesting and settlement of restricted stock units.
- Represents a weighted average sale price. Actual sale prices ranged from $6.6873 to $6.6876 per share. The reporting person undertakes to provide upon request by the Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within the range indicated.
Billionaire Hedge Funds
